Regular oral screening and vigilance: can it be a potential lifesaver?

Journal of Indian Society of Periodontology
Madhu Singh RatreAjay Parihar

Abstract

Acute myeloid leukemia (AML) is a malignant neoplasm of myeloid series defined by the presence of immature blast cells (>30%) in peripheral circulation. Oral manifestations are the potential indicators of systemic health and disease. Oral cavity is the frequently and early involved sites in AML. Gingival overgrowth due to leukemia is one such condition encountered by periodontists. Hence, understanding, identifying, and correlating oral manifestations with systemic diseases are the ultimate responsibility of every dental clinician because of its lethal and unpredictable course. In the present case, we are discussing an undiagnosed case of AML who presented to us with oral complaints.

Citations

Jun 25, 2020·Cancers·Francisco Cammarata-ScalisiMichele Callea

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy
bone

Related Concepts

Related Feeds

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Related Papers

Acta Odontologica Scandinavica
Lívia Azeredo Alves AntunesIvete Pomarico Ribeiro de Souza
Journal of Indian Society of Periodontology
S P K Kennedy BabuS Agila
Indian Heart Journal
K M Krishnamoorthy, Krishnakumar Nair
Medicina oral, patología oral y cirugía bucal
Paulo-Sérgio da Silva-SantosMarina G Magalhães
© 2022 Meta ULC. All rights reserved